RS49907B - Koncentrat delotvorne supstance sa formoterolom koji je duže upotrebljiv - Google Patents
Koncentrat delotvorne supstance sa formoterolom koji je duže upotrebljivInfo
- Publication number
- RS49907B RS49907B YUP-267/01A YU26701A RS49907B RS 49907 B RS49907 B RS 49907B YU 26701 A YU26701 A YU 26701A RS 49907 B RS49907 B RS 49907B
- Authority
- RS
- Serbia
- Prior art keywords
- formoterol
- active substance
- substance concentrate
- propellant
- storable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Koncentrat delotvorne supstance, koji ne sadrži potisno sredstvo, koji može da se skladišti (očuva). za pripremanje aerosolske formulacije koja ne sadrži potisno sredstvo, koji sadrži, formoterol u obliku njegove slobodne baze, njegovu farmakološki podnošljivu so ili neki njegov adicioni proizvod kao delotvornu supstancu, u farmaceutski podnošljivom rastvaraču ili suspenzionom sredstvu, pri čemu koncentracija formoterola iznosi između 75 mg/ml i 500 mg/ml. Prijava sadrži još 2 nezavisna zahteva i 15 zavisnih zahteva
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19847969A DE19847969A1 (de) | 1998-10-17 | 1998-10-17 | Lagerfähig flüssige Formulierung mit Formoterol |
US11238098P | 1998-12-14 | 1998-12-14 |
Publications (2)
Publication Number | Publication Date |
---|---|
YU26701A YU26701A (sh) | 2005-07-19 |
RS49907B true RS49907B (sr) | 2008-09-29 |
Family
ID=7884831
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
YUP-267/01A RS49907B (sr) | 1998-10-17 | 1999-10-09 | Koncentrat delotvorne supstance sa formoterolom koji je duže upotrebljiv |
Country Status (14)
Country | Link |
---|---|
US (1) | US6150418A (sr) |
AR (1) | AR020830A1 (sr) |
AT (1) | ATE218331T1 (sr) |
AU (1) | AU764126B2 (sr) |
CO (2) | CO5261514A1 (sr) |
DE (1) | DE19847969A1 (sr) |
EG (1) | EG23820A (sr) |
MY (1) | MY124329A (sr) |
PE (1) | PE20001226A1 (sr) |
RS (1) | RS49907B (sr) |
SA (1) | SA99200700B1 (sr) |
TW (1) | TW562676B (sr) |
UA (1) | UA71585C2 (sr) |
ZA (1) | ZA200103056B (sr) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19653969A1 (de) * | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Kg | Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole |
US20030215396A1 (en) * | 1999-09-15 | 2003-11-20 | Boehringer Ingelheim Pharma Kg | Method for the production of propellant gas-free aerosols from aqueous medicament preparations |
US20010031244A1 (en) * | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
DZ2947A1 (fr) | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
US20060171899A1 (en) * | 1998-12-10 | 2006-08-03 | Akwete Adjei | Water-stabilized aerosol formulation system and method of making |
US7074388B2 (en) * | 1998-12-10 | 2006-07-11 | Kos Life Science, Inc. | Water stabilized medicinal aerosol formulation |
GB9902689D0 (en) * | 1999-02-08 | 1999-03-31 | Novartis Ag | Organic compounds |
DE19921693A1 (de) * | 1999-05-12 | 2000-11-16 | Boehringer Ingelheim Pharma | Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika |
US20040002548A1 (en) * | 1999-05-12 | 2004-01-01 | Boehringer Ingelheim Pharma Kg | Medicament compositions containing anticholinergically-effective compounds and betamimetics |
US20100197719A1 (en) * | 1999-05-12 | 2010-08-05 | Boehringer Ingelheim Pharma Kg | Medicament compositions containing anticholinergically-effective compounds and betamimetics |
US6315985B1 (en) * | 1999-06-18 | 2001-11-13 | 3M Innovative Properties Company | C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability |
IT1313553B1 (it) | 1999-07-23 | 2002-09-09 | Chiesi Farma Spa | Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione. |
IT1317720B1 (it) * | 2000-01-07 | 2003-07-15 | Chiesi Farma Spa | Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani. |
IT1317846B1 (it) | 2000-02-22 | 2003-07-15 | Chiesi Farma Spa | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
IT1318514B1 (it) * | 2000-05-12 | 2003-08-27 | Chiesi Farma Spa | Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari. |
SK286694B6 (sk) * | 2000-05-22 | 2009-03-05 | Chiesi Farmaceutici S.P.A. | Aerosólový farmaceutický prostriedok |
JP2004509920A (ja) * | 2000-09-29 | 2004-04-02 | ボード オブ トラスティーズ オペレーティング ミシガン ステート ユニヴァーシティ | カテコールアミン医薬組成物および方法 |
ITMI20010428A1 (it) * | 2001-03-02 | 2002-09-02 | Chemo Breath S A | Composizioni ad uso inalatorio a base di formoterolo |
DE10111843A1 (de) * | 2001-03-13 | 2002-09-19 | Boehringer Ingelheim Pharma | Verbindungen zur Behandlung von inflammatorischen Erkrankungen |
US20020193394A1 (en) * | 2001-03-13 | 2002-12-19 | Bernd Disse | Compounds for treating inflammatory diseases |
US20030055026A1 (en) * | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
US6667344B2 (en) * | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
ES2222294T3 (es) * | 2001-07-02 | 2005-02-01 | Chiesi Farmaceutici S.P.A. | Formulacion optimizada de tobramicina para administracion en forma de aerosol. |
PT3536344T (pt) * | 2002-03-01 | 2020-03-26 | Chiesi Farm Spa | Formulação superfina de formoterol |
WO2003099290A1 (en) * | 2002-05-21 | 2003-12-04 | Glaxo Group Limited | Pharmaceutical products and methods of manufacture |
US20040166065A1 (en) * | 2002-08-14 | 2004-08-26 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosol formulation for inhalation comprising an anticholinergic |
AU2007231727B2 (en) * | 2002-09-03 | 2010-12-16 | Kos Life Sciences, Inc. | Water stabilized medicinal aerosol formulation |
US7040314B2 (en) * | 2002-09-06 | 2006-05-09 | Philip Morris Usa Inc. | Aerosol generating devices and methods for generating aerosols suitable for forming propellant-free aerosols |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
US20050026948A1 (en) * | 2003-07-29 | 2005-02-03 | Boehringer Ingelheim International Gmbh | Medicaments for inhalation comprising an anticholinergic and a betamimetic |
DE10345065A1 (de) * | 2003-09-26 | 2005-04-14 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum |
EP1595531A1 (en) * | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
KR20070000476A (ko) * | 2004-02-27 | 2007-01-02 | 키에시 파르마슈티시 엣스. 피. 에이. | 압축화 계량된 도스흡입용 안정된 약제용액 제제 |
CN100457087C (zh) * | 2004-02-27 | 2009-02-04 | 奇斯药制品公司 | 用于加压计量吸入器的稳定的药用溶液制剂 |
CA2562009A1 (en) * | 2004-04-05 | 2005-10-20 | Sepracor Inc. | (r,r)-formoterol in combination with other pharmacological agents |
ITRM20050022A1 (it) | 2005-01-19 | 2006-07-20 | Italchimici S P A | Formulazione farmaceutica di una soluzione stabile di glicole propilenico contenente formoterolo per via inalatoria e suo procedimento di preparazione. |
CA2716936C (en) * | 2008-02-26 | 2018-06-05 | Elevation Pharmaceuticals, Inc. | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations |
US20100055045A1 (en) | 2008-02-26 | 2010-03-04 | William Gerhart | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations |
GB201113662D0 (en) * | 2011-08-08 | 2011-09-21 | Prosonix Ltd | Pharmaceutical compositions |
MX2014011576A (es) * | 2012-04-11 | 2014-11-21 | Cipla Ltd | Composicion farmaceutica. |
US20200405700A1 (en) * | 2019-06-27 | 2020-12-31 | Cai Gu Huang | Inhalable formulation of a solution containing formoterol fumarate and aclidinium bromide |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8501015D0 (en) * | 1985-01-16 | 1985-02-20 | Riker Laboratories Inc | Drug |
US5795564A (en) * | 1991-04-05 | 1998-08-18 | Sepracor, Inc. | Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol |
SE9302777D0 (sv) * | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
ES2099415T3 (es) * | 1991-12-18 | 1997-05-16 | Minnesota Mining & Mfg | Formulaciones de aerosol en suspension. |
ATE213946T1 (de) * | 1991-12-18 | 2002-03-15 | Formoterol und budesonide enthaltende zusammensetzung | |
US5569450A (en) * | 1993-03-17 | 1996-10-29 | Minnesota Mining And Manufacturing Company | Aerosol formulation containing an ester-, amide-, or mercaptoester-derived dispersing aid |
GB9612297D0 (en) * | 1996-06-11 | 1996-08-14 | Minnesota Mining & Mfg | Medicinal aerosol formulations |
GB9616237D0 (en) * | 1996-08-01 | 1996-09-11 | Norton Healthcare Ltd | Aerosol formulations |
-
1998
- 1998-10-17 DE DE19847969A patent/DE19847969A1/de not_active Ceased
-
1999
- 1999-09-10 UA UA2001053340A patent/UA71585C2/uk unknown
- 1999-10-09 RS YUP-267/01A patent/RS49907B/sr unknown
- 1999-10-09 AU AU62019/99A patent/AU764126B2/en not_active Ceased
- 1999-10-09 AT AT99948972T patent/ATE218331T1/de not_active IP Right Cessation
- 1999-10-12 US US09/416,474 patent/US6150418A/en not_active Expired - Lifetime
- 1999-10-14 CO CO99065439D patent/CO5261514A1/es unknown
- 1999-10-14 MY MYPI99004451A patent/MY124329A/en unknown
- 1999-10-14 CO CO99065439A patent/CO5271759A1/es not_active Application Discontinuation
- 1999-10-15 PE PE1999001045A patent/PE20001226A1/es not_active Application Discontinuation
- 1999-10-15 AR ARP990105227A patent/AR020830A1/es not_active Suspension/Interruption
- 1999-10-15 TW TW088117879A patent/TW562676B/zh not_active IP Right Cessation
- 1999-10-17 EG EG129599A patent/EG23820A/xx active
- 1999-10-24 SA SA99200700A patent/SA99200700B1/ar unknown
-
2001
- 2001-04-12 ZA ZA200103056A patent/ZA200103056B/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW562676B (en) | 2003-11-21 |
MY124329A (en) | 2006-06-30 |
AR020830A1 (es) | 2002-05-29 |
EG23820A (en) | 2007-09-19 |
YU26701A (sh) | 2005-07-19 |
ATE218331T1 (de) | 2002-06-15 |
UA71585C2 (uk) | 2004-12-15 |
CO5271759A1 (es) | 2003-04-30 |
ZA200103056B (en) | 2002-01-23 |
AU764126B2 (en) | 2003-08-14 |
US6150418A (en) | 2000-11-21 |
CO5261514A1 (es) | 2003-03-31 |
PE20001226A1 (es) | 2000-11-01 |
DE19847969A1 (de) | 2000-04-20 |
AU6201999A (en) | 2000-05-08 |
SA99200700B1 (ar) | 2006-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS49907B (sr) | Koncentrat delotvorne supstance sa formoterolom koji je duže upotrebljiv | |
MEP44008A (en) | Pharmaceutical aerosol composition | |
HUP0103925A2 (hu) | Formoterolt tartalmazó, stabilan tárolható hatóanyag-koncentrátum | |
ES2157307T3 (es) | Composicion topica que contiene un antagonista de sustancia p. | |
DK0722313T3 (da) | Viskoelastiske sammensætninger af fluorerede organiske forbindelser | |
KR960000247A (ko) | 사이클로스포린a 함유 조성물 및 그의 제조방법 | |
KR860000865A (ko) | 약제 제형의 제조방법 | |
KR910000703A (ko) | 테트라졸 자극성 아미노산 수용체의 길항물질 | |
DE69725704D1 (de) | Konservierungssysteme fur cyclodextrine enthaltende arzneimittel | |
CA2352915A1 (en) | Pharmaceutical compositions containing mupirocin | |
SE9800729D0 (sv) | New topical formulation I | |
ES2187820T3 (es) | Formulaciones farmaceuticas de factor de liberacion de la corticotrop ina que tiene una estabilidad en su forma liquida. | |
DK1280558T3 (da) | Halvfast indgivelsesvehikel og farmaceutiske sammensætninger | |
KR910005876A (ko) | 모세혈관 취약증의 치료를 위한 극소용 약학적 조성물 | |
KR880007060A (ko) | 제약 조성물 | |
IT1255076B (it) | Microsfere biodegradabili ad uso farmaceutico e cosmetico | |
SE9403389D0 (sv) | Pharmaceutical composition containing derivattves of sex hormones | |
IE802033L (en) | Dibenzazepine derivatives | |
SE9800730D0 (sv) | New topical formulation II | |
KR960003717A (ko) | 항암제에 의해 유발되는 말초신경병의 예방에 유용한 의약의 제조를 위한 엘리프로딜 및 그 거울상이성질체의 이용 | |
RS50074B (sr) | Farmaceutski preparat koji sadrži paracetamol i drotaverin | |
IE37288L (en) | Crane assembly | |
KR927003530A (ko) | 이온삼투요법용 제약 제제의 제조에 있어서의 국소 마취제의 용도 | |
KR960021046A (ko) | 카페익산을 포함하는 b형 간염 치료제 | |
KR960021045A (ko) | 페루릭산을 포함하는 b형 간염 치료제 |